It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
www.springerlink.com...
Two influenza A viruses were isolated from pigs in Thailand in January 1988 during the early febrile stage of an influenza-like illness. The isolates contained hemagglutinin and neuraminidase antigens related to those of swine H1N1 influenza virus. This result based on the virus isolation is compatible with the epizootiological evidence that, unlike the human influenza with peak activity in summer (May–July), swine influenza virus is prevalent in the winter season (November–January) in Thailand. suggesting that they may be of the same origin.
sciencedirect.com
A swine influenza H1N1 virus was isolated from a pig during a severe outbreak of respiratory disease in Korea. All genes of the H1N1 isolate, including hemagglutinin (HA), neuraminidase (NA), matrix (M), nucleoprotein (NP), non-structural (NS), PA, PB1 and PB2, were of swine origin. Also, all these genes showed a close phylogenic relationship with those of H1N1 viruses previously isolated from pigs in the United States. These results suggest that North American swine influenza virus has actually been transmitted to pigs in Korea.
www.cdc.gov...
In Norway in January 2008, unprecedented levels of oseltamivir resistance were found in 12 of 16 influenza viruses A (H1N1) tested. To investigate the epidemiologic and clinical characteristics of these viruses, we used sequence analysis to test all available subtype H1N1 viruses from the 2007–08 season for resistance. Questionnaires from physicians provided information on predisposing diseases, oseltamivir use, symptoms, and complications. Clinical data were obtained for 265 patients. In total, 183 (67.3%) of 272 viruses were oseltamivir resistant. Resistance was not associated with prior use of antiviral drugs. Symptoms and hospitalization rates did not differ for patients infected with a resistant or a susceptible virus. Oseltamivir-resistant influenza viruses A (H1N1) did not show diminished capability to spread in the absence of selective pressure. The ability of these viruses to sustain their fitness and spread among persons should be considered when shaping future strategies for treating and preventing seasonal and pandemic influenza.
The influenza virus neuraminidase inhibitors zanamivir and oseltamivir were introduced into clinical practice in various parts of the world from 1999 through 2002 (1). Oseltamivir limits replication of both influenza A and B viruses (1). In most European countries, neuraminidase inhibitors are not widely used to treat seasonal influenza, but they are being stockpiled in many countries as part of their pandemic influenza preparedness.
the Norwegian national influenza center and at the Health Protection Agency confirmed the high proportion of oseltamivir resistance. This unexpected and unprecedented discovery had possible public health implications of international concern. On January 25, 2008, the Norwegian Institute of Public Health notified WHO of these findings under the International Health Regulations (6) and notified the European Commission through the Early Warning and Response System. The Institute also informed hospitals and physicians in Norway about a possible lack of therapeutic effect when treating patients with oseltamivir. By the end of January, oseltamivir-resistant viruses had been reported from several European countries (7).
Of 241 patients, 58 (24.1%) had >1 complications recorded, but no difference was observed between those infected with a resistant virus and those infected with a susceptible virus (Table 2). Bronchitis and pneumonia were the most frequent complications, reported for 22 and 17 patients, respectively. The age of the 17 patients who had pneumonia ranged from 8 months to 65 years (mean 29 years): 2 (12.5%) were 0–4 years of age, 5 (31.3%) were 5–14 years of age, 2 (12.5%) were 15–24 years of age, 4 (25.0%) were 25–59 years of age, and 3 (18.8%) were >59 years of age. Of the 17 patients with pneumonia, 15 were infected with a resistant virus.
Originally posted by Cloudsinthesky
I left something off my post........
They have been treating with Tamiflu.....
Many, I say many have returned to the ER sicker than when they have came in.
The hospital is working on seeing the effectiveness of Tamiflu........with concerns that it makes the "non" human strains more stronger against a weak immune system..
I have posted in several post that Tamiflu will not work against this strain......period!!
Originally posted by Cloudsinthesky
This was a post I made on the swine flu update board........This info is from a hospital in Charleston SC. The ER there has been flooded with flu like symptoms........many have tested positive with the info being withheld by the CDC......as far as tamiflu? This is what I was tolded........
Originally posted by Cloudsinthesky
I left something off my post........
They have been treating with Tamiflu.....
Many, I say many have returned to the ER sicker than when they have came in.
The hospital is working on seeing the effectiveness of Tamiflu........with concerns that it makes the "non" human strains more stronger against a weak immune system..
I have posted in several post that Tamiflu will not work against this strain......period!!
The biggest problem with Tamiflu is the side effects can be worse than the flu. The side effect only last about 6 hours but if you keep taking it well you get the idea.
I only took it once about a year ago as a "preventive" measure as everyone was sick here except myself (everyone in my family that is).
Within 2 hours of taking it I was hurling every 15 minutes for about 6 hours. Talk about dry heaves lol.
So I never took it again because if I kept taking it chances are I would have died. So treating with it is not a very good idea especially sense it doesn't seem to be effective, the only thing it will do is make things worse for people like me and chances are kill them not from the flu but from the side effects of the drug. Of course the flu will get blamed.
Originally posted by Memysabu
AJ said yesterday he just got ahold of a top secret military document that said tamiflu does not work on this virus.
Originally posted by Witness2008
reply to post by Extralien
The WHO seems to think Tamiflu will ease the suffering.
uk.reuters.com...
the Norwegian Institute of Public Health notified WHO of these findings under the International Health Regulations (6) and notified the European Commission through the Early Warning and Response System. The Institute also informed hospitals and physicians in Norway about a possible lack of therapeutic effect when treating patients with oseltamivir. By the end of January, oseltamivir-resistant viruses had been reported from several European countries
Originally posted by sickofitall2012
They know that tamiflu wasn't designed for this strain, because it's completely new, never seen before strain. I think they are using Tamiflu to keep people calm.
Originally posted by Hellmutt
If the flu is resistant to anti-viral drugs, is it also resistant to honey? Maybe honey can kill the flu? Either way, let's hope that the honey-bees don't die out.
www.delmartimes.net...
To ward off viruses, bacteria, inflammation, fungus infections, cholesterol gremlins, digestive ails, scratchy throats, colds and creatures of the night such as mosquitoes, ticks and the occasional vampire, garlic is loaded with allicin, a potent sulfur compound that has been credited with having the power of killing 23 types of bacteria, including salmonella and staphylococcus, also contains vitamins A, B6 and C; selenium; magnesium; potassium; calcium; zinc; and flavonoids. making this "stinky rose" a powerhouse antioxidant and immune booster as well as a heart healer by lowering bad cholesterol, regulating blood pressure, improving circulation and preventing stroke.
Studies have also shown that garlic's allicin promotes weight control, kills parasites, boosts the body's defenses against allergies and is a good friend to diabetics by lowering insulin and triglyceride levels.
The Japanese government has warned doctors that Tamiflu, the drug being stockpiled around the world as a defence against a bird flu pandemic, should not be prescribed to teenagers for fear that it can lead to bizarre and self-destructive behaviour.[...]
But for the past three years, there have been alarming stories of young people succumbing to fits of self-destructive behaviour while receiving Tamiflu.
Relatives who believe that their children were adversely affected by the drug have formed a lobby group to demand its withdrawal from sale.